Federal grant programs / Department of Health and Human Services

Biomedical Advanced Research and Development Authority (BARDA), Biodefense Medical Countermeasure Development (93.360)

• Awarded, FY 2021 to 2025$1.4 billion
• Grant awards211
• Typical award$957,641
• Awarded in FY 2025-$6.3 million
• Size rank213 of 1,823
• Type of assistanceCooperative agreements (discretionary grants), project grants (discretionary)

Key findings

• It is the 213th largest of 1,823 federal grant programs by five-year awards.
• The 20 largest recipients received 88% of the money.
• Awards went to recipients in 42 states and territories.

What the program funds

The purpose of this program is to coordinate the acceleration of countermeasure and product advanced research and development by—(A) facilitating collaboration between the Department of Health and Human Services and other Federal agencies, relevant industries, academia, and other persons, with respect to such advanced research and development; (B) promoting countermeasure and product advanced research and development; (C) facilitating contacts between interested persons and the offices or employees authorized by the Secretary to advise such persons regarding requirements under the Federal Food, Drug, and Cosmetic Act and under section 351 of the Public Health Service Act; and (D) promoting innovation to reduce the time and cost of countermeasure and product advanced research and development. The Public Health Service Act at 42 U.S.C. 247d-6a defines a qualified countermeasure as “…a drug (as that term is defined by section 321(g)(1) of title 21), biological product (as that term is defined by section 262(i) of this title), or device (as that term is defined by section 321(h) of title 21), that the Secretary determines to be a priority (consistent with sections 182(2) and 184(a) of title 6) to - (i) diagnose, mitigate, prevent, or treat harm from any biological agent (including organisms that cause an infectious disease) or toxin, chemical, radiological, or nuclear agent that may cause a public health emergency affecting national security; or (ii) diagnose, mitigate, prevent, or treat harm from a condition that may result in adverse health consequences or death and may be caused by administering a drug, biological product, or device that is used as described in this subparagraph”

From the federal Assistance Listing. Read the full listing on SAM.gov.

Open opportunities

No opportunity under this program is open or forecast on Grants.gov right now. Programs often post once a year, so the funding history below shows what to expect.

Rules from the program listing

Who can apply

All types of entities are eligible, including highly qualified foreign nationals outside the United States either alone or in collaboration with American participants when such transactions may inure to the benefit of the American people. Applicants should review the individual funding opportunity announcements issued under this CFDA program.

What the money can and cannot pay for

Support international in-country and domestic advanced development and industrialization of human pandemic influenza vaccine. Support activities related to the mitigation of the global shortage of influenza vaccines through awards and sub-awards to developing countries with the potential and capacity to manufacture various influenza vaccines. Basic research (e.g. scientific or medical experiments) is not allowable.;

Matching requirements

This program has no statutory formula. Matching requirements are not applicable to this assistance listing. MOE requirements are not applicable to this assistance listing.

Award range and average, in the agency's words

$30,000,000 to $55,000,000

Quoted from the program's federal Assistance Listing. The notice of funding opportunity is the official source for each competition's rules.

Who usually wins

Businesses received 65% of the money, colleges and universities 19% and small businesses 7.4%.

By state

33 states have a page for this program: those that received at least $1 million or 10 awards.

Award amounts are federal obligations reported to USAspending.gov for fiscal 2021 to 2025; see how our data works.